Investors>Press Release | 프레이저테라퓨틱스

KOR
- KOR
- ENG

Pipeline

Press Release

All 2

Search

Prazer Therapeutics Enters into Strategi..
Prazer Therapeutics Enters into Strategic Collaboration and License Agreement with Johnson & Johnson to Develop Novel Targeted Protei..

Prazer Tx 1,579 2026.01.09
KDDF Selects Nine Outstanding Projects f..
SoVarGen, Abion, Aimedbio, GI Innovation, Pin Therapeutics, D&D Pharmatech, Rznomics, Inventera, and Prazer Therapeutics Among Nine Selected ProjectsThe Korea Drug Developm..

프레이저테라퓨틱스 142 2025.12.16